Ali Hajigholami
1* 
, Hourieh Ansari
2 , Sakineh Ansari
1 , Shakiba Hassanzadeh
3 1 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Community and Preventive Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Nickan Research Institute, Isfahan, Iran
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease (COVID-19) pandemic is the largest infectious crisis in the present century. It has been reported that COVID-19 infection may trigger autoimmune diseases. Herein, we report a 68-year-old male that was diagnosed with thrombotic thrombocytopenic purpura (TTP) following COVID-19 infection. To our knowledge, this is the fourth case of COVID-19-associated TTP. More attention is required regarding the possibility of developing TTP in COVID-19 patients, especially with the presence of decreased consciousness and low levels of hemoglobin and platelet.
Implication for health policy/practice/research/medical education:
Coronavirus disease-19 (COVID-19) has been reported to trigger autoimmune diseases including thrombotic thrombocytopenic purpura (TTP). Therefore, more attention is recommended towards the possibility of developing TTP in COVID-19 patients.
Please cite this paper as: Hajigholami A, Ansari H, Ansari S, Hassanzadeh S. COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report. J Nephropharmacol. 2023;12(1):e10454. DOI: 10.34172/npj.2022.10454.